Previous 10 |
AUSTIN, Texas, Feb. 19, 2019 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM), a clinical-stage oncology company focused on the discovery and development of the company’s proprietary engineered toxin bodies (ETBs), which are differentiated, targeted, biologic therapeutics...
NEW YORK, Feb. 12, 2019 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Capital Review released its latest key findings for all current investors, traders, and shareholders of Overstock.com, Inc. (NASDAQ:OSTK), Regeneron Pharmaceuticals, Inc. (NASDAQ:REG...
NEW YORK, NY / ACCESSWIRE / September 20, 2018 / Despite any news yesterday, shares of Altimmune were soaring and closed up roughly 285%. It was in early September that the company announced positive mid-stage data on its intranasal egg-free flu vaccine candidate NasoVax . Shares of Molecul...
MTEM +51% on Takeda development deal . More news on: Molecular Templates, Inc., Tilray, Inc., Command Security Corporation, Stocks on the move, Top stock market news, , Read more ...
Thinly traded micro cap Molecular Templates (NASDAQ: MTEM ) is up 41% premarket on increased volume in response to its deal with Takeda Pharmaceutical ( OTCPK:TKPYY )( OTCPK:TKPHF ) for the joint development of CD38-targeted engineered toxin antibodies (ETBs) for the treatment ...
The Agreement Will Support the Development of a Potential New Treatment Option for Multiple Myeloma AUSTIN, Texas, Sept. 19, 2018 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq:MTEM) today announced an agreement with Takeda Pharmaceutical Company Limited (Takeda) for the...
NEW YORK,, Aug. 16, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Quanex Building Products Corporation (NYSE:NX), Molecular Templates Inc....
Molecular Templates (NASDAQ: MTEM ): Q2 EPS of -$0.36 misses by $0.11 . Revenue of $1.37M (+3325.0% Y/Y) Press Release More news on: Molecular Templates, Inc., Earnings news and commentary, Healthcare stocks news, ,
AUSTIN, Texas, Aug. 09, 2018 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq:MTEM, “Molecular” or “Molecular Templates”), a clinical-stage oncology company focused on the discovery and development of the company’s proprietary engineered toxin bo...
News, Short Squeeze, Breakout and More Instantly...
Molecular Templates Inc. Company Name:
MTEM Stock Symbol:
NASDAQ Market:
Molecular Templates Inc. Website:
AUSTIN, Texas, May 15, 2024 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage biopharmaceutical company focused on the discovery and development of proprietary targeted biologic therapeutics, engineere...